Sign in

Warren F. Bryant

Director at DOLLAR GENERALDOLLAR GENERAL
Board

About Warren F. Bryant

Warren F. Bryant, age 79, has served on Dollar General’s Board since 2009. He is the retired Chairman, President & CEO of Longs Drug Stores (Chairman 2003–2008; President & CEO 2002–2008) and previously was Senior Vice President at The Kroger Co. (1999–2002). He brings 40+ years of retail leadership spanning marketing, merchandising, operations, finance and policy-making, and is recognized by the Board for executive management, strategic planning and risk management expertise. He is an independent director and an Audit Committee financial expert.

Past Roles

OrganizationRoleTenureCommittees/Impact
Longs Drug Stores CorporationChairman of the Board2003–2008Leadership and policy-making in retail; strategic planning and risk oversight
Longs Drug Stores CorporationPresident & CEO2002–2008Executive management across marketing, merchandising, operations, finance
The Kroger Co.Senior Vice President1999–2002Large-scale retail operations and merchandising experience

External Roles

OrganizationRoleTenureCommittees/Impact
Loblaw Companies LimitedDirectorMay 2013–May 2022Board oversight in North American retail
OfficeMax IncorporatedDirector2004–2013Board service during strategic transitions
Office Depot, Inc.DirectorNov 2013–Jul 2017Board oversight post-merger consolidation
  • Current public company directorships: none disclosed in DG’s proxy (Bryant’s “Current Service on Other Public Boards” field is blank).

Board Governance

  • Committee memberships (2025): Audit Committee member; Compensation & Human Capital Management (CHCM) Committee member; not on Nominating, Governance & Corporate Responsibility (NGCR). Audit Chair: Ana M. Chadwick; NGCR Chair: Debra A. Sandler; CHCM Chair: Timothy I. McGuire.
  • Independence: The Board affirmatively determined Bryant is independent under NYSE standards and DG’s guidelines.
  • Audit Committee financial expert: Board determined Bryant is an “audit committee financial expert.”
  • Attendance: In 2024, the Board met 5 times; Audit 5; CHCM 8; NGCR 4. Each incumbent director attended at least 75% of applicable meetings; all directors serving at the time attended the 2024 annual meeting.
  • Share ownership guidelines (directors): 5x annual cash retainer; directors must hold 100% of net after-tax shares until target met. As of Jan 31, 2025, all non-employee directors except one (Santana) were in compliance or within grace period.

Fixed Compensation

Component (Fiscal 2024)Amount ($)Notes
Board cash retainer95,000 Standard board retainer; paid quarterly
Stock awards (RSUs)185,805 Annual RSU granted May 28, 2024; vests on first anniversary
All other compensation2,847 Dividend equivalents on unvested RSUs
Total283,652 Sum of components
  • Standard director program (2024): Board retainer $95,000; estimated annual RSU value $190,000; committee chair retainers: Audit $25,000, CHCM $20,000, NGCR $17,500. Bryant was not a committee chair.
  • RSU mechanics: Annual grants to non-employee directors vest on first anniversary; directors may elect to defer receipt of shares.

Performance Compensation

Pay ElementPerformance MetricWeighting/Terms
Director equity (RSUs)NoneTime-based vesting; no performance metrics for non-employee directors

DG’s performance metrics (Adjusted EBIT, Net Sales; PSUs with Adjusted EBITDA and Adjusted ROIC) apply to executives, not director pay.

Other Directorships & Interlocks

TypeCompanyOverlap/InterlockNotes
Prior public boardLoblaw Companies LimitedNone disclosedBryant director 2013–2022
Prior public boardOfficeMax IncorporatedNone disclosed2004–2013
Prior public boardOffice Depot, Inc.None disclosed2013–2017
Current public boardNone disclosed by DG
  • Related-party transactions: DG reported none >$120,000 involving directors in 2024–2025 YTD.
  • Review policy: Audit Committee oversees related-party transactions (except compensatory/charitable), with formal approval and annual review requirements.

Expertise & Qualifications

  • 40+ years in retail leadership, including marketing, merchandising, operations, finance, strategy and risk oversight; former chairman/CEO of Longs Drug Stores; prior SVP at Kroger.
  • Audit Committee financial expert designation; contributes financial literacy and risk oversight capabilities.
  • Board’s rationale: Extensive retail leadership and policy-making roles provide valuable strategic planning and ability to advise the CEO.

Equity Ownership

MetricValueAs of/Notes
Total beneficial ownership (shares)42,934 Rounded; includes share equivalents per SEC definition
Ownership as % of shares outstanding<1% (“*”) 219,947,078 shares outstanding (Record Date Mar 20, 2025)
RSUs/earned PSUs settleable within 60 days3,487 Included in beneficial ownership computation
Shared voting power (trusts)425 + 425 shares Christopher W. Bryant Legacy Trust; Jennifer M. Bryant Legacy Trust
Unvested RSUs (outstanding)1,333 Includes dividend equivalents; vest on first anniversary
Director ownership guideline5x cash retainer Compliance as of Jan 31, 2025 (Bryant within compliant cohort)
Hedging/pledging policyProhibitedNo pledging or hedging of DG stock by directors/officers
Insider trading policyAdopted; filed (10-K Exhibit 19)Company policy governs director trades

Governance Assessment

  • Strengths

    • Independent director; dual committee service (Audit; CHCM) enhances board effectiveness and continuity; audit financial expert designation strengthens oversight.
    • Attendance and engagement: Board/committee meeting cadence with minimum 75% participation met; directors attended 2024 annual meeting.
    • Ownership alignment: Director share ownership guidelines (5x retainer) with holding requirements; Bryant in compliant cohort; anti-hedging/pledging policy.
    • No related-party transactions >$120k involving directors, reducing conflict risk.
  • Watch items / RED FLAGS

    • Shareholder derivative actions name Bryant among defendants (alleging fiduciary duty breaches and related claims). Federal actions consolidated and stayed; state actions consolidated and stayed pending resolution in separate securities litigation. Legal exposure is a governance overhang.
    • Executive Say-on-Pay support of 72.8% in 2024 indicates investor concern on pay-for-performance; while not directly about director pay, it reflects broader governance sentiment. Board/CHCM engaged and made program changes for 2025.
  • Compensation Committee oversight and consultant independence: CHCM selects Pearl Meyer as independent adviser; evaluates consultant independence; Bryant sits on CHCM (signatory to CHCM report), supporting robust process and responsiveness to shareholder feedback.

Overall: Bryant’s independence, deep retail operating experience, Audit/CHCM roles, and compliance with ownership/anti-hedging policies support board effectiveness and alignment. Pending derivative litigation is a notable governance risk to monitor; absence of related-party transactions and strong committee processes mitigate conflict concerns.